Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? : a randomized controlled trial
- Author
- Leen Paelinck (UGent) , Akos Gulyban, Ferenc Lakosi, Tom Vercauteren (UGent) , Werner De Gersem (UGent) , Bruno Speleers (UGent) , Christel Monten (UGent) , THOMAS MULLIEZ, Patrick Berkovic, Annick Van Greveling (UGent) , Frederik Decoster (UGent) , Philippe Coucke, Wilfried De Neve (UGent) and Liv Veldeman (UGent)
- Organization
- Keywords
- Breast cancer, Whole-breast irradiation, Prone, Hypofractionation, Simultaneous integrated boost, MODULATED RADIATION-THERAPY, MONTHS FOLLOW-UP, CONSERVING THERAPY, CLINICAL-TRIAL, TUMOR BED, I-II, CANCER, RADIOTHERAPY, WHOLE, SURGERY
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.71 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8526543
- MLA
- Paelinck, Leen et al. “Does an Integrated Boost Increase Acute Toxicity in Prone Hypofractionated Breast Irradiation? : a Randomized Controlled Trial.” RADIOTHERAPY AND ONCOLOGY 122.1 (2017): 30–36. Print.
- APA
- Paelinck, L., Gulyban, A., Lakosi, F., Vercauteren, T., De Gersem, W., Speleers, B., Monten, C., et al. (2017). Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? : a randomized controlled trial. RADIOTHERAPY AND ONCOLOGY, 122(1), 30–36.
- Chicago author-date
- Paelinck, Leen, Akos Gulyban, Ferenc Lakosi, Tom Vercauteren, Werner De Gersem, Bruno Speleers, Christel Monten, et al. 2017. “Does an Integrated Boost Increase Acute Toxicity in Prone Hypofractionated Breast Irradiation? : a Randomized Controlled Trial.” Radiotherapy and Oncology 122 (1): 30–36.
- Chicago author-date (all authors)
- Paelinck, Leen, Akos Gulyban, Ferenc Lakosi, Tom Vercauteren, Werner De Gersem, Bruno Speleers, Christel Monten, THOMAS MULLIEZ, Patrick Berkovic, Annick Van Greveling, Frederik Decoster, Philippe Coucke, Wilfried De Neve, and Liv Veldeman. 2017. “Does an Integrated Boost Increase Acute Toxicity in Prone Hypofractionated Breast Irradiation? : a Randomized Controlled Trial.” Radiotherapy and Oncology 122 (1): 30–36.
- Vancouver
- 1.Paelinck L, Gulyban A, Lakosi F, Vercauteren T, De Gersem W, Speleers B, et al. Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? : a randomized controlled trial. RADIOTHERAPY AND ONCOLOGY. 2017;122(1):30–6.
- IEEE
- [1]L. Paelinck et al., “Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? : a randomized controlled trial,” RADIOTHERAPY AND ONCOLOGY, vol. 122, no. 1, pp. 30–36, 2017.
@article{8526543,
author = {Paelinck, Leen and Gulyban, Akos and Lakosi, Ferenc and Vercauteren, Tom and De Gersem, Werner and Speleers, Bruno and Monten, Christel and MULLIEZ, THOMAS and Berkovic, Patrick and Van Greveling, Annick and Decoster, Frederik and Coucke, Philippe and De Neve, Wilfried and Veldeman, Liv},
issn = {0167-8140},
journal = {RADIOTHERAPY AND ONCOLOGY},
keywords = {Breast cancer,Whole-breast irradiation,Prone,Hypofractionation,Simultaneous integrated boost,MODULATED RADIATION-THERAPY,MONTHS FOLLOW-UP,CONSERVING THERAPY,CLINICAL-TRIAL,TUMOR BED,I-II,CANCER,RADIOTHERAPY,WHOLE,SURGERY},
language = {eng},
number = {1},
pages = {30--36},
title = {Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? : a randomized controlled trial},
url = {http://dx.doi.org/10.1016/j.radonc.2016.12.023},
volume = {122},
year = {2017},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: